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Introduction
RNA interference (RNAi) was discovered in 1998 as a mech-
anism for gene regulation on the mRNA level by small RNA.1 
The most popular exponents are siRNA and microRNA. In 
their active form, both are short double-stranded RNAs (21 
base pairs (bp)), which guide gene silencing through comple-
mentarity to their target mRNA.2–5 The capability of siRNA 
to specifically knockdown a gene of interest holds a huge 
therapeutic potential, and plenty of research is focused 
on its efficient delivery to its target site.5–9 A well-studied 
approach in nonviral gene therapy is the complexation of 
nucleic acids with cationic polymers.10–12 Due to its small 
size, siRNA generally forms less stable inter-electrolyte com-
plexes than plasmid DNA.13 Increasing the size and charge 
density of siRNA is therefore an option to tackle this prob-
lem and hence to increase its transfection efficiency. Short 
DNA overhangs are known to have a positive effect on cel-
lular uptake.14 Larger assemblies can be achieved by other 
approaches such as noncovalent polymerization of siRNA 
via sticky ends15 or employing disulfide chemistry.16,17 The 
number of siRNA units in such multimeric assemblies is 
largely not well defined. A strategy commonly pursued is 
the formation of larger defined structures containing multiple 
siRNA units.18–20 DNA oligomers can be used as a framework 
to merge several siRNA units into one construct.21,22 DNA is 
especially suitable for this purpose as it is simply accessible 
and a huge variety of structures can be assembled by Wat-
son Crick base pairing. As DNA is a natural molecule, it can 
be degraded by endogenous pathways and consequently 
toxicity is deemed unlikely.23,24 From simple structures such 
as polyhedrons25–27 up to very complex designs using the 
DNA origami approach,28–30 various different shapes have 
been established from which only a few have been tested 
for siRNA delivery. Examples include a DNA tetrahedron or a 
DNA nanotube conjugated to siRNA and folate, which could 
be delivered to folate receptor–bearing cells.31,32
The current work provides an overview of how DNA adap-
tor molecules can be used to improve cellular delivery of 
siRNA in polyplexes employing sequence-defined cationic 
polymers. These polymers33 possess protonable amines and 
optionally additional functional units like targeting ligands,34 
shielding,35 and endosomolytic domains36 to overcome the 
barriers for efficient DNA/RNA transfer to the target cell. DNA 
oligonucleotides provide versatile opportunities for exten-
sion, multimerization, and functionalization of siRNA, which 
we studied in a comparative way. The idea was to figure out 
which parameters are of importance with respect to polyplex 
formation and transfection efficiency.
A siRNA connected via the 3′ end of the passenger strand 
to a 181-nucleotide adaptor DNA extension turned out to be 
the best transfecting construct, whereas merging multiple 
siRNA units into one construct was less effective. Addition-
ally, the endosomolytic influenza peptide INF-737 could be 
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siRNA and microRNA are promising therapeutic agents, which are engaged in a natural mechanism called RNA interference 
that modulates gene expression posttranscriptionally. For intracellular delivery of such nucleic acid triggers, we use sequence-
defined cationic polymers manufactured through solid phase chemistry. They consist of an oligoethanamino amide core 
for siRNA complexation and optional domains for nanoparticle shielding and cell targeting. Due to the small size of siRNA, 
electrostatic complexes with polycations are less stable, and consequently intracellular delivery is less efficient. Here we use 
DNA oligomers as adaptors to increase size and charge of cargo siRNA, resulting in increased polyplex stability, which in turn 
boosts transfection efficiency. Extending a single siRNA with a 181-nucleotide DNA adaptor is sufficient to provide maximum 
gene silencing aided by cationic polymers. Interestingly, this simple strategy was far more effective than merging defined 
numbers (4–10) of siRNA units into one DNA scaffolded construct. For DNA attachment, the 3′ end of the siRNA passenger 
strand was beneficial over the 5′ end. The impact of the attachment site however was resolved by introducing bioreducible 
disulfides at the connection point. We also show that DNA adaptors provide the opportunity to readily link additional functional 
domains to siRNA. Exemplified by the covalent conjugation of the endosomolytic influenza peptide INF-7 to siRNA via a DNA 
backbone strand and complexing this construct with a targeting polymer, we could form a highly functional polyethylene glycol–
shielded polyplex to downregulate a luciferase gene in folate receptor–positive cells.
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successfully connected to siRNA via a DNA adaptor result-
ing in a folate-targeted, polyethylene glycol (PEG)–shielded 
polyplex with high gene silencing efficiency.
Results
DNA backbone for siRNA extension
The basic structure used for this approach is composed of 
two siRNAs directed against eGFP linked by a 79-nucleo-
tide DNA backbone strand. In detail, the siRNA consists of 
a chemically modified guide strand and a chemically modi-
fied complementary passenger strand with either a 5′ or a 
3′ 18-nucleotide DNA extension. Via the extensions, the 
siRNAs are hybridized to both ends of the DNA backbone 
strand resulting in structure 1bb2si (= 1 backbone strand + 2 
siRNAs) (Figure 1a). The sequences for all oligonucleotides 
used in this work can be found in Supplementary Table S1. 
The construct is formed by mixing the components in their 
respective molar amounts, heating to 95 °C, and slow cooling 
to room temperature (RT). The assembly of the construct is 
accomplished by building the structure from its subunits and 
monitoring the retention of each by native polyacrylamide 
gel electrophoresis (PAGE). All assemblies were clean and 
showed the expected difference in migration (Figure 1b). 
For transfection, the nanostructure was complexed with the 
three-armed cationic polymer 689.36 Each arm contains three 
protonable succinoyl tetraethylene pentamine (Stp) units for 
complexation of the negatively charged nucleic acids, four 
histidines that promote endosomal escape through the pro-
ton-sponge effect,38 and terminal cysteines for polyplex stabi-
lization through disulfide bond formation (Figure 1c). To test 
whether 1bb2si has already advantages over a canonical 
siRNA format in transfection-mediated gene silencing experi-
ments, it was mixed with polymer 689 at an amine to phos-
phate ratio of 6 (N/P ratio of 6, including all phosphates from 
siRNA and DNA) and transfected into murine neuroblastoma 
N2A/eGFPLuc cells that stably express an eGFP–luciferase 
fusion protein in medium supplemented with 10% fetal bovine 
serum (FBS).
Luciferase is downregulated upon gene silencing of the eGF-
PLuc fusion mRNA and represents a convenient quantitative 
readout for subsequent transfections. The siRNA was used at 
a concentration of 0.36 µM, and the polyplexes were incubated 
on the cells for 48 hours. Luciferase knockdown is specified as 
relative to a buffer-treated cell control. As expected, the canon-
ical siRNA already exhibited a high gene silencing efficiency, 
but it was outperformed by 1bb2si. A control was included to 
verify that the hybridization of the siRNA to the DNA back-
bone strand is necessary. siRNA without DNA extensions was 
mixed with the respective amount of the DNA backbone strand 
(1bb2si-unconj). Silencing by 1bb2si-unconj was comparable 
with that of the canonical siRNA. Thus the beneficial effect of 
the nanostructure cannot be achieved by mixing siRNA with 
DNA without prior conjugation of complementary DNA exten-
sions (Figure 2a). To challenge the effectiveness of 1bb2si, 
the incubation time was decreased to 1.5 hours and the siRNA 
concentration was reduced to 0.2 µM. While gene silencing of 
1bb2si remained as good as in the previous experiment, the 
efficiency of the canonical siRNA as well as of 1bb2si-unconj 
was significantly reduced (Figure 2b).
To examine whether the enhanced transfection efficiency 
is due to the formation of more stable polyplexes, a compara-
tive binding assay of canonical siRNA and 1bb2si at different 
N/P ratios was performed on an agarose gel. After complex-
ation, charge neutralized particles remain in the pocket while 
free nucleic acids migrate into the gel. For 1bb2si, the reten-
tion was nearly complete already at N/P ratio of 3, indicating 
that only a low polymer excess is necessary to form stable 
polyplexes proofing complete binding of the construct. In con-
trast, with canonical siRNA even at a N/P ratio of 24 still free 
siRNA could be detected (Figure 2c).
Influence of polymer and siRNA concentration
The previous transfections were conducted at a constant N/P 
ratio of 6. As extension of siRNA with DNA comes along with 
an increase in phosphates per unit, the amount of polymer 
used for complexation of 1bb2si was higher than for siRNA. 
To exclude that the positive effect is due to the increase in 
polymer amount, the transfections were repeated at constant 
Figure 1. Assembly of DNA nanostructures for polyplex 
formation. (a) Basic building block consisting of two siRNAs with a 
DNA extension at the 3′ or 5′ terminus of the passenger strand used 
for hybridization to both ends of a DNA backbone strand (1bb2si). 
Unconjugated control consisting of two equivalents siRNA mixed 
with one equivalent backbone strand (1bb2si-unconj). (b) Assembly 
of 1bb2si from its subunits verified on a native polyacrylamide gel 
(Bb: DNA backbone strand; p5′: passenger strand with 5′ DNA 
extension; p3′: passenger strand with 3′ DNA extension; g: guide 
strand, gel cropped). (c) Polymer 689 for complexation of the DNA 
nanostructures (C: cysteine; H: histidine; Stp: succinoyl tetraethylene 
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polymer concentrations of 1.7 and 4.1 µM (corresponding to 
a N/P ratio of 6 for both, the canonical siRNA and 1bb2si). In 
both cases, the prior results could be reproduced  (Figure 2b). 
Considering this fact, subsequent transfections were con-
ducted at a constant polymer concentration of 1.7 µM.
To examine the influence of the siRNA concentration, 
the amount of 1bb2si and canonical siRNA was varied 
and transfection efficiency was compared. The maximal 
reduction of luciferase expression was achieved for both 
samples at 0.1 µM (siRNA 50%, 1bb2si: 10%). A further 
increase in concentration had no effect (Figure 2d). This 
proves that the gene silencing efficiency of 1bb2si cannot 
be achieved by raising the siRNA concentration. Within the 
examined range, the advantage of 1bb2si over canonical 
siRNA is independent of N/P ratio, polymer, and siRNA 
concentration.
Complex or simple structures?
More sophisticated multimeric siRNA structures can eas-
ily be formed with the building block 1bb2si (Figure 3). By 
annealing three of these constructs through their DNA back-
bone, a three-armed structure containing six siRNA units was 
assembled (3bb6si). A five-armed structure containing 10 
siRNA units was constructed by the same strategy (5bb10si) 
and a four-armed structure with only one siRNA per arm was 
assembled by linking two 1bb2si building blocks by two DNA 
backbone strands (4bb4si).
The larger constructs were less defined on a native PAGE 
gel (Supplementary Figure S1) and also transfection effi-
ciency decreased with increased number of siRNA units per 
structure (Supplementary Figure S2).
Hence, the next step was to consider more simple struc-
tures than 1bb2si, which can be achieved by testing the 
subunits of 1bb2si for gene silencing (Figure 4a). This pro-
vides also an insight into the possible cause of the enhanced 
transfection efficiency of 1bb2si. Constructs extended by 
18 DNA nucleotides either at the 3′- or 5′-end of the pas-
senger strand (siRNA/3′ov, siRNA/5′ov) are already slightly 
more efficacious compared with canonical siRNA. However, 
hybridizing either of the two constructs separately to the DNA 
backbone strand (1bb1si/3′ov and 1bb1si/5′ov, respectively) 
boosts transfection efficiency even more. Single siRNA con-
struct 1bb1si/3′ov performs equally well as dimer siRNA 
construct 1bb2si (Figure 4b). This indicates that attaching 
more siRNAs to one structure is not necessarily beneficial. 
It can even be detrimental as shown in the previous experi-
ment (Supplementary Figure S2). What seems to matter is 
an extension of a single siRNA by adaptor DNA. Regarding 
the attachment site of the DNA extension, the 3′ extended 
structures exhibited an increased gene silencing efficiency 
Figure 2. Transfection efficiency and stability of polyplexes formed with polymer 689 and siRNA, 1bb2si or 1bb2si-unconj. (a) eGFP–
luciferase knockdown in N2A/eGFPLuc cells with 0.36 µM anti-eGFP siRNA at N/P ratio of 6 and 48 hours of incubation time. (b) Comparison 
of eGFP–luciferase knockdown at constant N/P ratio and constant polymer concentration with 0.2 µM siRNA and 1.5 hours of incubation time. 
(c) Binding assay for canonical siRNA and 1bb2si at different N/P ratios. Complexed nucleic acids remain in the loading pocket while free 
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compared with their 5′ counterparts. All substructures of 
1bb2si possess single-stranded DNA regions of different 
length (siRNA/3′ov: 18 bases, 1bb2si: 43 bases, 1bb1si/3′ov: 
61 bases). As single strands are more flexible than double 
strands, this might be a requirement for stable particle forma-
tion and hence increased transfection efficiency. To test this 
hypothesis, the respective double-stranded equivalents were 
assembled and examined for luciferase knockdown with poly-
mer 689 (siRNA/3′ov-ds, 1bb1si/3′ov-ds, 1bb2si-ds, Supple-
mentary Figure S3). siRNA/3′ov-ds and 1bb2si-ds and their 
single-stranded counterparts resulted in a similar silencing 
efficiency, indicating that a single-stranded domain is not a 
requirement. In contrast, 1bb1si/3′ov-ds showed a reduced 
knockdown. The stiffness of its long unnicked double strand 
might destabilize polyplexes.
Optimal length of DNA sequence per siRNA
Given the results above, we asked the question whether 
there is an optimum DNA sequence length connected to a 
single siRNA. Due to a better transfection efficacy of DNA 
extension at the passenger strand’s 3′-terminus compared 
with the 5′-counterparts, we decided to probe a potential 
DNA sequence length bias with a sequential DNA extension 
approach. DNA strands with a complementary part to the pre-
vious extension and a 20-nucleotide part for further extension 
were used to assemble the different sized defined structures 
(Ext I, Ext II, Ext III, Ext IV, Ext V; Figure 5a). The assembly of 
the constructs was verified by native PAGE (Figure 5b). We 
observed a positive correlation of gene silencing efficiency 
and construct size. siRNA/3′ov with a single-stranded DNA 
overhang displays improved silencing activity as compared 
with canonical siRNA without overhang. Double-stranded 
DNA extensions up to Ext II resulted in strong increase in 
potency. Larger constructs (Ext III to V) did not increase 
transfection efficiency further (Figure 5c). This indicates that 
in this setup, conjugation of a single siRNA to an at least 
99-nucleotide DNA extension provides the maximum silenc-
ing effect. As all constructs contain a similarly long stretch 
of 20-nucleotide single-stranded DNA, the positive effect of 
flexible single-strandedness on polycation complexation can 
be ruled out as major cause for the enhancement.
Reducible versus nonreducible siRNA attachment
In all previous experiments, irrespective of the siRNA’s termi-
nus, the DNA extension is covalently connected to the pas-
senger strand via a phosphodiester linkage. It is possible that 
this chemistry prevents the siRNA from gaining full activity. This 
























Figure 4. Transfection efficiency of the subunits of 1bb2si. (a) 
Schematic representation of the subunits of 1bb2si and (b) luciferase 
knockdown after complexation with polymer 689. Canonical siRNA 
and 1bb2si were compared with the 5′ or 3′ passenger strand 
extended constructs with and without hybridization to the DNA 
backbone strand. The unconjugated controls consist of siRNA 
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assumption is supported by the difference in efficiency of the 
5′ and 3′ extended passenger strand. To test this hypothesis, 
we engineered a biocleavable disulfide linker between the RNA 
and the DNA extension sequence. We wanted to utilize the 
cytosol’s reducing environment to cleave the disulfide bond, 
which should leave the siRNA in a more accessible form for the 
RNA-induced silencing complex (RISC).
In order to implement this strategy, we used two thiol 
modified 18-nucleotide DNA strands, each complementary 
to one end of the 79-nucleotide backbone strand that was 
used for the assembly of 1bb2si. An eGFP-siRNA with a 
5′ thiolated passenger strand was activated with 5,5′-dithio-
bis-(2-nitrobenzoic acid) and coupled to the thiolated DNA 
strand. The respective constructs from the previous experi-
ments were assembled using the disulfide-extended siRNA 
(SS-1bb1si/5′ov, SS-1bb1si/3′ov, SS-1bb2si) (Figure 6a). 
Verification of the structures was again performed with native 
PAGE (Figure 6b). All three structures showed a very effi-
cient gene silencing activity similar to the one of 1bb2si 
 (Figure 6c). In contrast to the previous experiments, the 
DNA extensions are attached to the 5′ end of the siRNA pas-
senger strand. The decreased silencing potential observed 
for the nonreducible 5′ end extended construct could be 
overcome by incorporation of the disulfide linker. The pas-
senger strand extended constructs without backbone strand 
(SS-siRNA/3′ov, SS-siRNA/5′ov) even outperformed their 
nonreducible equivalents.
The silencing for the outstanding structures had reached 
a level that made it hard to draw conclusions on the effect 
of the bioreducible attachment of the siRNA or the larger 
stepwise-extended structures. Therefore, the best perform-
ing constructs were further compared by determining their 
EC
50 values (Supplementary Figures S4 and S5). The dif-
ference between the structures remained nonsignificant with 
the following exceptions. The EC50 value of SS-1bb1si/3′ov 
(19.9 nM) was approximately twofold higher than the EC50 
value of the remaining structures containing the 79-nucleo-
tide backbone strand. In case of the step-by-step extended 
siRNA, Ext IV (181 nucleotides, EC50 of 4.4 nM) performed 
significantly better than Ext II (99 nucleotides, EC50 of 
11.7 nM) for which luciferase knockdown was already satu-
rated at 0.2 µM siRNA. None of the structures led to a signifi-
cant decrease in metabolic activity as determined at a siRNA 
concentration of 0.2 µM with MTT(3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) assay (Supplemen-
tary Figure S6). No significant luciferase knockdown was 
observed when the eGFP-siRNA was replaced with a con-
trol siRNA for the bioreducible constructs (Supplementary 
 Figure S7). Hence, the reduced luciferase expression can be 
attributed to RNAi-mediated knockdown.
Polyplex stability analysis by agarose gel retardation assay 
revealed no major differences between the larger structures 
(Supplementary Figure S8). Dynamic light scattering mea-
surements revealed that polyplexes of polymer 689 and the 
siRNA constructs present heterogeneous populations of 
nanoparticles with sizes in the submicrometer range and high 
polydispersity indices (Supplementary Table S2). Like for 
many related cationic carriers, probably multiple thousands 
Figure 5. Optimal sequence length of DNA backbone. (a) Schematic representation of the stepwise DNA extended siRNA. Each 
extension step is accomplished by a DNA strand with one segment complementary to the previous extension and a 20-nucleotide segment 
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of siRNAs are aggregated into the several hundred nanome-
ter polyplexes. Thus the lack of significant size differences 
between the different siRNA constructs is not surprising.
Different polycations for siRNA transfection
So far, polymer 689 was used to test the effect of DNA exten-
sion of siRNA on transfection efficiency. It is also of interest if 
these findings hold true for more commonly used transfection 
agents like polyethyleneimine (PEI), or for lipid-containing 
formulations such as lipopolymer 454. The latter contains six 
tyrosines and two oleic acid units, which provide excellent 
stabilization through hydrophobic interactions and endo-
somal lysis through membrane destabilization. The fatty acid 
unit is connected to two identical arms consisting of two Stp 
units, three tyrosines for stabilization, and a terminal cysteine 
(Supplementary Figure S9).39
Hence, siRNA, 1bb2si, and 1bb2si-unconj were complexed 
with linear PEI and lipopolymer 454 at two different polymer 
concentrations (corresponding to N/P ratio of 6 for siRNA 
and 1bb2si, respectively) and tested for gene silencing effi-
ciency (Supplementary Figure S10) and metabolic activity 
 (Supplementary Figure S11) in N2A/eGFPLuc cells. Poly-
plexes formed with linear PEI and canonical siRNA worked at 
neither concentration, while polyplexes formed with linear PEI 
and 1bb2si mediated gene silencing (Supplementary Fig-
ure S10 left) to some extent. In contrast, if the well- stabilizing 
lipopolymer 454 was used for complexation, canonical siRNA 
already exhibited an efficient knockdown (82%), which could 
not be achieved by 1bb2si (60%). Both constructs were com-
pared at their optimum polymer concentration (3.9 µM for 
siRNA, 9.2 µM for 1bb2si) (Supplementary Figure S10 right).
Consequently one can assume that the findings for 
polymer 689 can be translated to other polycationic trans-
fection agents such as PEI lacking lipidic moieties. For lipid- 
containing delivery agents, the additional stabilizing effect of 
the DNA extensions appears not to be necessary or even 
counterproductive.
Attachment of functional domains to siRNA
Stabilization of siRNA polyplexes is only one requirement 
for successful nucleic acid delivery. Receptor targeting for 
improved and specific intracellular uptake8,40 and transport 
across the endolysosomal barrier41,42 are additional steps 
where functionalization can be beneficial. Disulfide chemistry 
provides the option to attach other functional units through 
the DNA backbone strand to the siRNA. INF-7 is a lytic pep-
tide known to promote endosomal escape.37 It was coupled 
to the 3′ thiol–modified DNA extension sequence by the 
peptide’s N-terminal cysteine. A construct containing one 
5′ passenger strand extended siRNA connected via the DNA 
backbone to INF-7 was assembled as previously described 
(SS-1bb1si/3′ov-INF) (Figure 7a). As expected, after com-
plexation with polymer 689, the inclusion of INF-7 had no 
advantage over the respective construct without INF-7 
(SS-1si1bb/3′ov) (Figure 6c). The histidines of polymer 
689 already promote sufficient endosomal escape. Hence, 
Figure 6. Bioreducible conjugation of the siRNA to the DNA backbone using disulfide chemistry. (a) Schematic representation of 
the structures from previous experiments with a disulfide linker introduced between the 5′ passenger strand and the DNA extension. For 
SS-1bb1si/3′ov-INF, influenza peptide 7 is conjugated to the 5′ DNA extension via its cysteine. (b) Verification of correct assembly by native 
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polymer 356, lacking histidines, was used to verify a positive 
effect of INF-7 as part of the nanostructure (Figure 7a).
Polymer 356 is a three-armed polymer of which two arms 
contain positively charged Stp units and terminal cysteines 
for polyplex stabilization. The third arm contains 24 ethylene 
glycol units (PEG24) for shielding and enhanced solubility 
and, in addition, folic acid to promote specific cellular uptake 
in folate receptor–expressing cells.43
The polyplexes were incubated on folate receptor–positive 
KB/eGFPLuc cells with an incubation time of 1 hour and a 
siRNA concentration of 0.2 µM. Indeed, SS-1bb1si/3′ov-INF 
showed a great increase in silencing over SS-1bb1si/3′ov 
and canonical siRNA without reduction in metabolic activ-
ity as part of a highly functional folate-targeted and PEG-
shielded polyplex (Figure 7b and Supplementary Figure 
S12). Folate receptor targeting was verified by testing the 
formulation in a ligand competition assay using folate-con-
taining medium (Supplementary Figure S13). In addition, 
lack of gene silencing by using ligand-free polymer 188 was 
demonstrated (Supplementary Figure S13). This proves 
that functional units can be attached to siRNA in a very sim-
ple way via a tunable DNA adaptor that improves polyplex 
stability itself (Supplementary Figure S14).
Discussion
This study demonstrates how siRNA can be extended 
by DNA adaptors to improve complex formation with 
sequence-defined cationic polymers, resulting in improved 
gene silencing efficiency. We tested several DNA/siRNA 
nanostructures ranging from DNA extension of one siRNA 
up to structures where two to ten siRNA units are merged 
into one construct. Delivery could be improved remarkably 
after complexation with a three-armed cationic polymer. 
Interestingly, the larger structures containing multiple siR-
NAs were less potent than the simple ones with one or two 
siRNA units. The observed key criterion for efficacy was the 
simple extension of siRNA with DNA to provide a sufficient 
number of negative charges.
We could figure out in a step-by-step extension of a sin-
gle siRNA that a prolongation of up to 181 DNA nucleotides 
results in a significant improvement of transfection efficiency.
An additional finding was that a 3′ DNA extended siRNA 
passenger strand is advantageous over a 5′ extended one. 
We speculate that 5′ DNA extensions disturb RISC loading 
or passenger strand removal. We can exclude differences 
in secondary structure of the DNA extension being respon-
sible for this effect as this observation is also present when 
the extension is hybridized to a DNA backbone strand. So 
when conjugating siRNA to DNA, the 3′ end of the passenger 
strand should be chosen as attachment site.
This fact indicates that steric hindrance is an issue to con-
sider. To overcome this limitation, we introduced a reducible 
disulfide linker between the 5′ siRNA passenger strand and 
the DNA extension, which should liberate the siRNA from the 
DNA adaptor in the cytosol. With this strategy, it was possible 
to enhance the performance of the 5′ extension constructs to 
the level of their 3′ counterparts. Hence if siRNA should be 
modified on both ends of the passenger strand, a reducible 
conjugation should be considered for the 5′ terminus.
Eventually, we could lift these findings to a more general 
level as DNA extension of siRNA is also beneficial when using 
linear PEI as transfection agent. This is well in agreement 
with the previous finding showing enhanced activity of linear 
PEI when using sticky siRNA.15 In contrast, when lipopolymer 
454 was used containing both fatty acids and tyrosines for 
polyplex stabilization,39 transfection efficiency could not be 
further improved by siRNA extensions. The already known 
high siRNA polyplex stability apparently makes an additional 
stabilizing effect by DNA extended siRNAs dispensable.
Importantly, we also showed that a DNA backbone strand 
cannot only be used for extension or connection of multiple 
siRNAs but also to include other functional domains in a very 
simple way. Thiolated DNA extensions can be conjugated to 
any thiol-containing functional molecule. Through hybridiza-
tion with the DNA backbone strand, the functional unit can 
be linked to siRNA. As a proof of concept, we conjugated the 
endosomolytic peptide INF-7 via a 79-nucleotide DNA back-
bone strand to siRNA. The INF-7–modified DNA backbone 
strand, which can be further optimized in terms of length 
and structure for each application, improved transfection effi-
ciency and polyplex stability with the multifunctional polymer 
356.
This strategy resulted in a straightforward construction of 
defined folate receptor–targeted siRNA polyplexes, contain-
ing all key elements for functional delivery, including particle 
surface shielding by PEG, bioreversible stabilization by disul-
fide bonding, folate as receptor-targeting ligand, and INF-7 
for endosomal escape.
Figure 7. Conjugation of INF-7 to siRNA via a DNA backbone 
strand. (a) Polymer 356 for complexation of SS-1bb1si/3′ov-INF (C: 
cysteine; Stp: succinoyl tetraethylene pentamine; K: lysine; PEG24: 
polyethylene glycol consisting of 24 ethylene glycol units; FolA: 
folic acid) and schematic representation of SS-1bb1si/3′ov-INF. (b) 
Transfection efficiency of siRNA hybridized to the DNA backbone 







































































Assembly of the constructs. All DNA sequences used in this 
work were designed with NUPACK.44 The constructs were 
assembled in assembly buffer (10 mM Tris-Cl; 5 mM MgCl2; pH 
7.5) to yield a concentration of 1–6 µM. The components were 
mixed in their respective molar amount, incubated at 95 °C for 
5 minutes, and cooled to RT at a rate of ca. 2 °C/minute. We 
used eGFP-siRNA with a chemically modified guide strand 
(g: UGCUUGUCGGCcAUGAuAUdTsdT, Axolabs, Kulmbach, 
Germany) and dependent on the experiment one of the fol-
lowing passenger strands: p5′: dGdCdCdGdGdAdTdCdGd 
CdCdAdCdAdTdAdAdCAuAucAuGGccGAcAAGcA-dTsdT; 
p3′: AuAucAuGGccGAcAAGcAdTsdTdCdGdAdCdGdGdAd 
TdAdTdAdCdAdTdG-dAdCdG; pSS: C6SSC6-AuAucAuGG 
ccGAcAAGcAdTsdT; and a siCTRL control sequence (g: 
CuAAuAcAGGCcAAuAcAUdTsdT; p: C6SSC6-AuGuAuuGG 
ccuGuAuuAGdTsdT; Axolabs). Upper case letters A, C, G, 
and U represent RNA nucleotides, lower case letters a, c, g, 
and u are 2’-O-methyl-nucleotides, dA, dC, dG, and dT code 
for DNA nucleotides, and s represents a phosphorothioate 
linkage. C6SSC6 is a symmetrical hexyl-disulfide linker. The 
DNA backbone strands were purchased from Sigma Aldrich 
(Hamburg, Germany).
Purification with high pressure liquid chromatography. Puri-
fication of the DNA extensions coupled via a disulfide bond 
to the siRNA passenger strand or INF-7 was performed with 
high pressure liquid chromatography (VWR Hitachi Chromas-
ter consisting of 5430 Diode array detector and 5160 gradient 
pump, Darmstadt, Deutschland). The products were separated 
with a waters XTerra C8 column (5 µm, 4.6 × 150 mm, Waters, 
Eschborn, Germany) and eluted with an acetonitrile /0.1 M tri-
ethylammonium acetate gradient (95:5 to 35:65 in 30 minutes). 
The collected fractions were lyophilized and stored at −20 °C.
Coupling of DNA extensions to siRNA passenger strands 
via a disulfide bond. Disulfide-modified siRNA was reduced 
with buffered tris(2-carboxyethyl)phosphine (700 times 
molar excess, Sigma Aldrich) for 2.5 hours at RT. Tris(2-
carboxyethyl)phosphine was removed by EtOH precipi-
tation. The remaining pellet was activated with 2.5 mM 
5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB, 17 times molar 
excess, Sigma Aldrich) for 1 hour at RT. The activated siRNA 
was purified by EtOH precipitation and dissolved in 20 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 8.4. 
The absence of dimers was verified with native PAGE. Disul-
fide-modified DNA extensions were reduced with buffered 
tris(2-carboxyethyl)phosphine (700 times excess), purified 
by EtOH precipitation, and dissolved in 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid buffer. The activated siRNA 
and the reduced DNA extensions were combined at a con-
centration of 50 µM and incubated at RT for 1 hour. Reaction 
was completed upon standard freezing to −20 °C, presum-
ably facilitated by the temporarily high concentrations in the 
mother liquor. The products were purified by EtOH precipita-
tion and high pressure liquid chromatography. Their correct 
size and purity were verified by native PAGE.
Coupling of DNA extension strands to INF-7. The cysteine of 
the INF-7 peptide (GLFE AIEG FIEN GWEG MIDG WYGC)37 
was activated with DTNB (17 times molar excess) and 
purified by high pressure liquid chromatography. The prod-
uct was incubated with thiolated DNA extension in 20 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid pH 8.4 
for 1 hour at RT and frozen to −20 °C. The product was again 
purified by high pressure liquid chromatography and verified 
by agarose gel electrophoresis.
Polyplex formation. Sequence-defined polymers 689, 356 and 
lipopolymer 454 were synthesized by solid phase–assisted 
synthesis as described in our previous publications.33,39,43 The 
siRNA and the required amount of polymer were separately 
diluted in 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid-buffered 5% glucose pH 7.4 in a final volume of 10 µl. Both 
solutions were pooled and incubated for 45 minutes at RT.
Cell culture. Murine neuroblastoma (N2A/eGFPLuc) or 
human cervix carcinoma (KB/eGFPLuc) cells, each stably 
transfected with an enhanced green fluorescent protein GL3 
firefly luciferase fusion protein,40,43,45 were cultured at 37 °C 
in Dulbecco’s modified Eagle’s Medium with 1 g/l glucose 
(for N2A), or folate-free Roswell Park Memorial Institute 
1640 medium (for KB), respectively, in both cases supple-
mented with 10% FBS, 4 mM glutamine, 100 U/ml penicillin, 
and 100 µg/ml streptomycin (Life Technologies, Darmstadt, 
Germany). For maintenance, the cells were detached with a 
trypsin-ethylenediaminetetraacetic acid solution (0.25%) and 
seeded at the desired concentration.
Transfection. N2A/eGFPLuc or KB/eGFPLuc cells were 
seeded in 96-well plates in 100 µl medium (N2A/eGFPLuc: 
5,000 cells per well in Dulbecco’s modified Eagle’s Medium, 
1g/l glucose, 10% FBS, KB/eGFPluc: 4,000 cells per well in 
folate-free Roswell Park Memorial Institute 1640 medium, 
10% FBS). After 24 hours, the medium was exchanged with 
80 µl of fresh medium. The formed polyplexes containing 
the eGFP-siRNA for downregulation of the eGFP–lucifer-
ase fusion protein were added in a volume of 20 µl to each 
well. After the desired incubation time, the medium was 
exchanged with 100 µl fresh medium. Forty-eight hours after 
the transfection, the cells were incubated with 100 µl of lysis 
buffer (25 mM Tris, pH 7.8, 2 mM ethylenediaminetetraacetic 
acid, 2 mM 1,4-dithiothreitol, 10% glycerol, 1% Triton X-100). 
Thirty-five microliters of the lysate was used for luciferase 
activity determination with a luciferase assay kit (100 ml of 
Luciferase Assay Buffer, Promega, Mannheim, Germany) 
in a luminometer (Centro LB 960 plate reader luminometer, 
Berthold Technologies, Bad Wildbad, Germany).
siRNA binding assay. siRNA (500 ng) or siRNA/DNA con-
jugate and the amount of polymer corresponding to the 
required N/P ratio were diluted separately in 20 mM HEPES-
buffered 5% glucose, pH 7.4 in a volume of 10 µl. The solu-
tions were pooled and incubated at RT for 45 minutes. After 
addition of 4 µl of loading buffer (prepared from 6 ml of glyc-
erine, 1.2 ml of 0.5 M ethylenediaminetetraacetic acid, 2.8 ml 
of H
2O, 0.02 g of bromophenol blue), the polyplexes were run 
on a 1.5% agarose gel at 90 V for 45 minutes.
MTT assay. Cells were transfected in 96-well plates as 
described earlier. Forty-eight hours after transfection, 10 µl 
www.moleculartherapy.org/mtna
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of MTT solution (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) were added to a final concentration of 
0.5 mg/ml. The plate was incubated at 37 °C for 2 hours for 
formation of the insoluble purple formazan. The medium was 
removed, and the plate was stored at −80 °C for at least 1 
hour. Hundred microliters of dimethyl sulfoxide was added to 
each well which dissolved the formazan and was quantified 
through its absorbance at 530 nm using a microplate reader 
(Tecan Spectrafluor Plus, Tecan, Männedorf, Switzerland). 
Results are presented relative to buffer treated control cells.
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